Defective insulin secretion in pancreatic β cells lacking type 1 IGF receptor

Journal of Clinical Investigation

Volumn 110, Issue 7, 2002, Pages 1011-1019

  Xuan, Shouhong ^a   Kitamura, Tadahiro ^a   Nakae, Jun ^a   Politi, Katerina ^a   Kido, Yoshiaki ^a   Fisher, Peter E ^a   Morroni, Manrico ^b   Cinti, Saverio ^b   White, Morris F ^c   Herrera, Pedro L ^d   Accili, Domenico ^a,e   Efstratiadis, Argiris ^a  

^a Columbia University ^*  (United States)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^c HARVARD UNIVERSITY   (United States)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e Berrie Research Pavilion   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN TYROSINE KINASE; SOMATOMEDIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIVISION; CELL PROLIFERATION; DIABETOGENESIS; ELECTRON MICROSCOPY; GENOTYPE; GLUCOSE TOLERANCE; INSULIN RELEASE; MOUSE; MUTAGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 0036791398     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI0215276     Document Type: Article

References (70)

1. Matschinsky, F.M. 1996. Banting Lecture 1995. A lesson in metabolic regulation inspired by the glucokinase glucose sensor paradigm. Diabetes. 45:223-241.
2. Bonner-Weir, S. 1994. Regulation of pancreatic beta-cell mass in vivo. Recent Prog. Horm. Res. 49:91-104.
3. Bonner-Weir, S. 2000. Life and death of the pancreatic beta cells. Trends Endocrinol. Metab. 11:375-378.
4. Shaw, J., and Latimer, E. 1925. Regeneration of pancreatic tissue from the transplanted pancreatic duct in the dog. Am. J. Physiol. 76:49-53.
5. Bendayan, M. 1987. Presence of endocrine cells in pancreatic ducts. Pancreas. 2:393-397.
6. Bettelli, E., Regoli, M., Orazioli, D., and Bendayan, M. 2001. Association between islets of Langerhans and pancreatic ductal system in adult rat. Where endocrine and exocrine meet together? Diabetologia, 44:575-584.
7. Bonner-Weir, S., et al. 2000. In vitro cultivation of human islets from expanded ductal tissue. Proc. Natl. Acad. Sci. USA. 97:7999-8004.
8. Bouwens, L., and Pipeleers, D.G. 1998. Extra-insular beta cells associated with ductules are frequent in adult human pancreas. Diabetologia. 41:629-633.
9. Hart, A.W., Baeza, N., Apelqvist, A., and Edlund, H. 2000. Attenuation of FGF signalling in mouse beta-cells leads to diabetes. Nature. 408:864-868.
10. Garcia-Ocana, et al. 2000. Hepatocyte growth factor overexpression in the islet of transgenic mice increases beta cell proliferation, enhances islet mass. and induces mild hypoglycemia. J. Biol. Chem. 275:1226-1232.
11. Vasavada, R.C., et al. 2000. Targeted expression of placental lactogen in the beta cells of transgenic mice results in beta cell proliferation, islet mass augmentation, and hypoglycemia. J. Biol. Chem. 275:15399-15406.
12. Rhodes, C.J. 2000. IGF-I and GH post-receptor signaling mechanisms for pancreatic beta-cell replication. J. Mol. Endocrinol, 24:303-31
13. Withers, DJ., et al. 1999. Irs-2 coordinates Igf-1 receptor-mediated betacell development and peripheral insulin signalling. Nat. Genet. 23:32-40.
14. Hugl, S.R., White, M.F., and Rhodes, C.J. 1998. Insulin-like growth factor I (IGF-I)-stimulated pancreatic beta-cell growth is glucose-dependent. Synergistic activation of insulin receptor substrate-mediated signal transduction pathways by glucose and IGF-I in INS-1 celis. J. Biol. Chem. 273:17771-17779.
15. Khan, F.A., Goforth, P.B., Zhang, M., and Satin, L.S. 2001. Insulin activates ATP-sensitive K(+) channels in pancreatic beta-cells through a phosphatidylinositol 3-kinase-dependent pathway. Diabetes. 50:2192-2198.
16. Leibiger, I.B., Leibiger, B., Moede, T., and Berggren, P.O. 1998. Exocytosis of insuiin promotes insulin gene transcription via the insulin receptor/PI 3-kinase/p70 s6 kinase and CaM kinase pathways. Mol. Cell. 1:933-938.
17. Leibiger, B., et al. 2001. Selective insulin signaling through a and b insulin receptors regulates transcription of insulin and glucokinase genes in pancreatic beta cells. Mot. Cell. 7:559-570.
18. Persaud, S.J., Harris, T.E., Burns, C.J., and Jones, P.M. 1999. Tyrosine kinases play a permissive role in glucose-induced insulin secretion from adult rat islets. J. Mol. Endocrinol. 22:19-28.
19. Aspinwall, C.A., et al. 2000. Roles of insulin receptor substrate-1, phosphatidylinositol 3-kinase, and release of intracellular Ca2+ stores in insulin-stimulated insulin secretion in beta-cells. J. Biol. Chem. 275:22331-22338.
20. Withers, D.J., et al. 1998. Disruption of IRS-2 causes type 2 diabetes in mice. Nature. 391:900-904.
21. Kubota, N., et al. 2000. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes. 49:1880-1889.
22. Pende, M., et al. 2000. Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature. 408:994-997.
23. Tuttle, R.L., et al. 2001. Regulation of pancreatic beta-cell growth and survival by the serine/thteonine protein kinase Aktl/PKBalpha. Nat. Med. 7:1133-1137.
24. Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C., and Permutt, M. 2001. Transgenic mice expressing a constitutively active Akc1/PKBα in pancreatic islet β-cells exhibit striking hypertrophy, hyperplasia and hyperinsulinemia. J. Clin. Invest. 108:1631-1638.
25. Kulkarni, R.N., et al. 1999. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell. 96:329-339.
26. Kulkarni R.N., et al. 1999. Altered function of insulin receptor substrate-1-deficient mouse islets and cultured beta-cell lines. J. Clin. Invest. 104:R69-R75.
27. Eto, K., et al. 2002. Phosphatidylinositol 3-kinase suppresses glucose-stimulated insulin secretion by affecting post-cytosolic [Ca(2+)] elevation signals. Diabetes. 51:87-97.
28. Zawalich, W.S., and Zawalich, K.C. 2000. A link between insulin resistance and hyperinsulinemia: inhibitors of phosphatidylinositol 3-kinase augment glucose-induced insulin secretion from islets of lean but not obese, rats. Endocrinology. 141:3287-3295.
29. Zhang, Q, Berggren, P.O., Larsson, O., Hall, K., and Tally, M. 1998. Insulin-like growth factor II inhibits glucose-induced insulin exocytosis. Biochem. Biophys. Res. Commun. 243:117-121.
30. Zhao, A.Z., Zhao, H., Teague, J., Fujimoto, W., and Beavo, J.A. 1997. Attenuation of insulin secretion by insulin-like growth factor 1 is mediated through activation of phosphodiescerase 3B. Proc. Nad. Acad. Sci. USA. 94:3223-3228.
31. Leahy, J.L., and Vandekerkhove, K.M. 1990. Insulin-like growth factor-I at physiological concentrations is a potent inhibitor of insulin secretion. Endocrinology. 126:1593-1598.
32. Pecrik, J., et al. 1999. A low protein diet alters the balance of islet cell replication and apoptosis in the fetal and neonatal rat and is associated with a reduced pancreatic expression of insulin-like growth factor-II. Endocrinology. 140:4861-4873.
33. Hill, DJ., Hogg,J., Perrik, J., Arany, E., and Han, V.K. 1999. Cellular distribution and ontogeny of insulin-like growth factors (IGFs) and IGF binding protein messenger RNAs and peptides in developing rat pancreas. J. Endocrinol. 160:305-317.
34. Hoog, A., et al. 1996. Increased amounts of a high molecular weight insulin-like growth factor II (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of diabetic Goto-Kakizaki rats. Endocrinology. 137:2415-2423.
35. Portela-Gomes, G.M., and Hoog, A. 2000. Insulin-like growth factor II in human fetal pancreas and its co-localization with the major islet hormones: comparison with adult pancreas. J. Endocrinol. 165:245-251.
36. Scaglia, L., Cahill, C.J., Finegood, D.T., and Bonner-Weir, S. 1997. Apoptosis participates in the remodeling of the endocrine pancreas in the neonatal rat. Endocrinology. 138:1736-1741.
37. Petrik J., Arany, E., McDonald, T.J., and Hill, DJ. 1998. Apoptosis in the pancreatic islet cells of the neonatal rat is associated with a reduced expression of insulin-like growth factor II that may act as a survival factor. Endocrinology. 139:2994-3004.
38. Devedjian, J.C., et al. 2000. Transgenic mice overexpressing insulin-like growth factor-II in beta cells develop type 2 diabetes. J. Clin. Invest. 105:731-740.
39. Rossetti, L., et al. 1996. Hepatic overexpression of insulin-like growth factor-II in adulthood increases basal and insulin-stimulated glucose disposal in conscious mice. J. Biol. Chem. 271:203-208.
40. Petrik, J, et al. 1999. Overexpression insulin-like growth factor-II in transgenic mice is associated with pancreatic islet cell hyperplasia. Endocrinology. 140:2353-2363.
41. Liu,J.P., Baker, J., Perkins, A.S., Robertson, E.J., and Efstratiadis, A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell. 75:59-72.
42. Dietrich, P., Dragatsis, I., Xuan, S., Zeitlin, S., and Efscratiadis, A. 2000. Conditional mutagenesis in mice with heat shock promoter-driven cre transgenes. Mamm. Genome. 11:196-205.
43. Herrera, P.L. 2000. Adult insulin- and glucagon-producing cells differentiate from two independent cell lineages. Development. 127:2317-2322.
44. Di Cola, G, Cool, M.H., and Accili, D. 1997. Hypoglycemic effect of insulin-like growth factor-1 in mice lacking insulin receptors. J. Clin. Invest. 99:2538-2544.
45. Kido, Y., et al. 2000. Tissue-specific insulin resistance in mice with combined mutations of insulin receptor, IRS-1 and IRS-2. J. Clin. Invest. 105:199-205.
46. Kitamura, T., et al. 2001. Preserved pancreatic beta-cell development and function in mice lacking the insulin receptor-related receptor. Mot. Cell. Biol. 21: 5624-5630.
47. Klein, U., et al. 2001. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J. Exp. Med. 194:1625-1638.
48. Aronoff, S.L., Bennett, P.H., Gorden, P., Rushforth, N., and Miller, M. 1977. Unexplained hyperinsulinemia in normal and "prediabetic" Pima Indians compared with normal Caucasians. An example of racial differences in insulin secretion. Diabetes. 26:827-840.
49. Lillioja, S., et al. 1991. Exaggerated early insulin release and insulin resistance in a diabetes-prone population: a metabolic comparison of Pima Indians and Caucasians. J. Clin. Endocrinol. Metab. 73:866-876.
50. O'Rahilly, S., Turner, R.C., and Matthews, D.R. 1988. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl. J. Med. 318:1225-1230.
51. Herman, W.H., et al. 1994. Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes. 43:40-46.
52. Byrne, M.M., et al. 1996. Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes. 45:1503-1510.
53. Bell, G.I., and Polonsky., K.S. 2001 Diabetes mellitus and genetically programmed defects in beta-cell Function. Nature. 414:788-791.
54. Accili, D., Kido, Y., Nakae, J., Lauro, D., and Park, B.-C. 2001. Genetics of type 2 diabetes: insights from targeted mouse mutants. Curr. Mol. Med. 1:9-23.
55. Flier, S.N., Kulkarni, R.N., and Kahn, C.R. 2001. Evidence for a circularing islet cell growth factor in insulin-resistant states. Proc. Natl. Acad. Sci. USA. 98:7475-7480.
56. Bonner-Weir, S. 2000. Perspective: postnatal pancreatic beta cell growth. Endocrinology. 141:1926-1929.
57. Accili, D. 2001. A kinase in the life of the beta cell. J Clin. Invest. 108:1575-1576.
58. Kitamura, T., et al. 2001. The transcription factor FKHR regulates pancreatic beta cell survival. Diabetes. 50(Suppl. 2):A345.
59. Henquin, J. 1992. The biophysical events involved in the stimulation of insulin release by arginine. In Guanidino compounds in biology and medicine. P. DeDeyen, B. Marescau, V. Stalon, and I. Qureshi, editors. John Wiley & Co. New York, New York, USA. 109-116.
60. Charles, S., Tamagawa, T., and Henquin, J.C. 1982. A single mechanism for the stimulation of insulin release and 86Rb+ efflux from rat islets by cationic amino acids. Biochem. J. 208:301-308.
61. Henquin, J.C. 2000. Triggering and amplifying pathways of regulation of insulin secretion by glucose. Diabetes. 49:1751-1760.
62. Hill, DJ., Sedran, R.J., Brenner, S.L., and McDonald, T.J. 1997. IGF-I has a dual effect on insulin release from isolated, perifused adult rat islets of Langerhans. J. Endocrinol. 153:15-25.
63. Kanzaki, M., et al. 1999. Translocation of a calcium-permeable cation channel induced by insulin-like growth factor-I. Nat. Cell Biol. 1:165-170.
64. Zhang, Q., et al. 1997. Insulin-like growth factor II signaling through the insulin-like growth factor II/mannose-6-phosphate receptor promotes exocytosis in insulin-secreting cells. Proc. Natl. Acad. Sci. USA. 94:6232-6237.
65. Lang,J. 1999. Molecular mechanisms and regulation of insulin exocytosis as a paradigm of endocrine secretion. Eur. J. Biochem. 259:3-17.
66. Hagenfeldt-Johansson, K.A., et al. 2001. Beta-cell-targeted expression of a dominant-negative hepatocyte nuclear factor-1 alpha induces a maturity-onset diabetes of the young (MODY)3-like phenotype in transgenic mice. Endocrinology. 142:5311-5320.
67. Yamagata, K., et al. 2002. Overexpression of dominant-negative mutant hepatocyte nuclear factor-lalpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-Cadherin, reduced beta-cell proliferation, and diabetes. Diabetes. 51:114-123.
68. Pontoglio, M., et al. 1998. Defective insulin secretion in hepatocyte nuclear factor 1alpha-deficient mice. J. Clin. Invest. 101:2215-2222.
69. Yang, Q., et al. 2002. Hepatocyte nuclear factor-1alpha modulates pancreatic beta-cell growth by regulating the expression of insulin-like growth factor-1 in INS-1 cells. Diabetes. 51:1785-1792.
70. Kulkarni, R.N., et al. 2002. Beta-cell-specific deletion of the IgF1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat. Genet. 31:111-115.